DRI Healthcare to Host Second Quarter 2025 Earnings Call and Webcast on August 14, 2025
DRI Healthcare Comments on FDA Approval and our Increased Investment in KalVista Pharmaceuticals' Ekterly® (sebetrals...
DRI Healthcare Announces Closing of Internalization Transaction
DRI Healthcare Trust Comments on FDA Delay for KalVista Pharmaceuticals' Sebetralstat PDUFA Goal Date Due to FDA Reso...
DRI Healthcare Trust Announces Appointment of Annalisa King to Board of Trustees and as Chair of the Audit Committee
2025 First Quarter Earnings Call
DRI Healthcare Trust Announces Voting Results of AGM
DRI Healthcare Trust Reports First Quarter 2025 Results and Announces Internalization of Manager
DRI Healthcare Trust to Host First Quarter 2025 Earnings Call and Webcast on May 13, 2025